Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05133_nanopub.RAHeKVrRUeQjAH4Z1bQmm9PcqFoZvxN6o0e-z5KM1Shm0#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05133 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05133 label "VP025 [drugbank:DB05133]" assertion.
- drugbank:DB05133 seeAlso DB05133 assertion.
- drugbank:DB05133 identifier "drugbank:DB05133" assertion.
- drugbank:DB05133 description "VP025, a novel drug formulation based on phospholipid microparticles incorporating phosphatidylglycerol, can inhibit neuroinflammation. VP025 may inhibit immune system activation and protect motoneurons from injury. It also shows the ability to reduce inflammation across the blood-brain barrier and improve correlates of memory and learning function. It is being developed to target the chronic inflammation within the central nervous system that is associated with a number of neurological diseases, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (Lou Gehrig’s disease). It is considered to be a systemic anti-inflammatory and neuroprotective agent." assertion.
- drugbank:DB05133 title "VP025" assertion.
- drugbank:DB05133 bio2rdf_vocabulary:identifier "DB05133" assertion.
- drugbank:DB05133 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05133 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05133" assertion.
- drugbank:DB05133 bio2rdf_vocabulary:x-identifiers.org DB05133 assertion.
- drugbank:DB05133 drugbank_vocabulary:drugbank-id "DB05133" assertion.
- drugbank:DB05133 drugbank_vocabulary:x-cas cas: assertion.